msp12389 (@msp12389) profile picture

Biotech

SF
Joined November 2013
Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)Photo by msp12389 (@msp12389)
$NUVB GSK/Nuvalent zidesamtinib - strong first line data. 15% CR. Roughly a year from market.
Dr. @alexdrilon at #WCLC26 presents 1L cohort of ARROS-1 trial of zidesamtinib in pts with ROS1 NSCLC. What a waterfall plot. RR 94% with 15% CR. mPFS not reached, PFS at 6m was 96% and at 12m was 90%. Intracranial RR 100%. In 78 pts who did not have brain metastases at baseline, no CNS events occurred to date. These are fantastic outcomes.
1
5
873
$UNCY the second CRL appears to confirm that the company resubmitted without the third party having addressed the deficiencies. $UNCY "believed" progress had been made. Incredible incompetence, if true download.open.fda.gov/crl/CR…
$UNCY received a second CRL for the exact same manufacturing issue and basically admits they resubmitted because they “believed” the third-party vendor had made enough progress. What a joke!
1
7
2,201
Of the four biotech stocks with bad news today, which one has the most upside from here $ABVX, $FULC, $CELC, $PRAX
61%$ABVX
12%$PRAX
5%$FULC
21%$CELC
57 votes • Final results
1
1,049
$ABVX This would be a good time to post some LLY corporate jet flight logs
1
13
1,193
LLY BD team seen leaving $ABVX headquarters
8
973
$REPL on CNBC at 10.40 ET.
1
690
$REPL This thread 👍 - but hey, "innovation died today" 🤷‍♂️🤯
Replying to @MaverickNY
Just how bad is it? It's pretty bad in my book. The FDA letter documents a pattern going well beyond weak science into what seems like a deliberate strategy to ignore regulators and hope for the best.
1
12
2,443
$REPL While we are at it, has $QURE ever shown evidence of all the "agreements in writing" they have with the FDA?
2
12
2,740
Dude, they told them >5 years ago, long before you and everyone elese started ranting about the "new" "bad" FDA" "Or is it the FDA that's lost all credibility. After a year of politically aligning staff, it will take a long time repairing the agency." $REPL
$repl all the docs that wrote the letter last year for why RP1 should be approved and attensed the subsequent FDA meeting obviously have no credibility. Or is it the FDA that's lost all credibility. After a year of politically aligning staff, it will take a long time repairing the agency.
3
1
1
14
3,696
$REPL A lot of biotwitter "influencers" looking very foolish today- wild CRL download.open.fda.gov/crl/CR…
5
709
yup 🤯 $REPL
$REPL CRL is WILD...these guys lied for fucking years. Also FDA is absolutely correct here, management story never made sense, cant comp Gr3 to Gr4 population. Also censoring PD in retreated patients is dirty. V little chance this beats opdualag on OS imo this company should die.
1
6
1,325
$REPL but but but... Prasad... FDA...
Can they read? seriously dude, this is egregious behavior from $REPL
3
1,192
$CRVS cash <$0.80/share
8
1,110